Although these results are in agreement with the protective role of PPARγ against influenza, they also suggest variability in the different PPARγ ligands in their efficacy and suggest that the kinetics of activation of the IL-4/STAT-6 signaling pathway by influenza infection could be a critical factor. This evidence concerns the gene STAT6 and influenza.